RPMI 6666

87081807, human blood, Lymphoblast

• UNSPSC-Code: 41106514

Eigenschaften

• product name: RPMI 6666, 87081807
• Biologische Quelle: human blood
• Wachstumsmodus: Suspension
• Karyotyp: 2n = 46
• Morphologie: Lymphoblast
• Produkte: Immunoglobulin
• Rezeptoren: Not specified
• Methode(n): cell culture | mammalian: suitable
• Relevante Krankheit(en): cancer
• Versandbedingung: dry ice
• Lagertemp.: −196°C

Beschreibung

Ursprung der Zelllinie

Human Caucasian lymphoblast, Hodgkins disease

Beschreibung der Zelllinie

Derived from a 29 year old male Caucasian with Hodgkin′s disease. One of a large series of permanent lines from leukocytes in the peripheral blood of donors with and without malignancies. Has cell-associated EBV and produces immunoglobulins. This cell line was initially thought to have been derived from Hodgkin lymphoma, but is now known to be an EBV-positive B-lymphoblastoid cell line.

Anwendung

Tumourigenicity studies

Nährmedium

RPMI 1640 + 2mM Glutamine + 20% Foetal Bovine Serum (FBS).

Subkultur-Routine

Maintain cultures between 3-9x100,000 cells/ml; 5% CO₂; 37°C.

Sonstige Hinweise

Additional freight & handling charges may be applicable for Asia-Pacific shipments. Please check with your local Customer Service representative for more information.